Interlinking of Hypoxia and Estrogen in Thyroid Cancer Progression

E-ISSN： 1875-533x|21|11|1351-1360

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.11, 2014-04, pp. : 1351-1360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 4, 2017-02 ,pp. : 235-248

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-01 ,pp. : 367-377

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib may improve response rate and progression-free survival (PFS) duration in patients with iodine refractory thyroid cancer

Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Hypoxia-directed cancer therapy

By Frazier Monica C Simons Jonathan W Zhong Hua Mabjeesh Nicola J

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 777-788

Informa Healthcare

Access to resources Recommend Favorite

Epigenetics of cancer progression

By Vucic Emily A Brown Carolyn J Lam Wan L

Pharmacogenomics, Vol. 9, Iss. 2, 2008-02 ,pp. : 215-234

Future Medicine

Access to resources Recommend Favorite